BofA Securities Upgrades Texas Instruments to Neutral

Analyst: Vivek Arya 1 min read Reproduced verbatim
Rating
Neutral
from Underperform
Target
$235
from $185 (+27%)
Outcome
Reached
on April 22, 2026

Bank of America’s latest target on Texas Instruments is now $320 (Apr 24, 2026); the median of 17 firms is $330. Bank of America has reached 79% of its year-old targets (67 scored).

Bank of America and Texas Instruments logos

What the analyst said

BofA Securities analyst Vivek Arya upgraded Texas Instruments (NASDAQ: TXN) from Underperform to Neutral with a price target of $235.00 (from $185.00).

“TXN delivered an in-line Q4 though with stronger GM (industrial mix) and FCF (capex control). Q1 outlook was the star of the show, guided up +2% QoQ/+11% YoY to $4.5bn midpoint ahead of consensus’ $4.4bn and normal seasonality flat/slightly down.

TXN commentary was more optimistic than extremely bullish, likely because of last year’s mixed trends. Still, we positively highlight management’s commentary re improving backlog, order trends, data center strength (9% of sales, up 64% YoY in CY25) and potential for continued FCF growth.

On the negative side, TXN avoided any discussion of factory loadings to not signal potential Q2 trends. All-in, we raise CY26/27E pf-EPS by 8%/7% to $6.23/$7.12 and take our PO to $235 from $185, now on 33x CY27E PE vs 28x prior on better recovery momentum and visibility, but still within historical 17x-36x range.

Related, our FCF forecasts move up 14-1-5% for CY26/27E towards $7.13/$8.20 per share, leaving room for management’s longer-term outlook for $8-$12/share. Upcoming capital management event (Feb-24) next catalyst and could feature more steps towards achieving FCF targets and improved returns/buybacks.

Our Neutral rating signals a balanced mix of improving FCF but below peer sales growth (8-10% vs peers growing double digits).”

Cite this note: Price Target, "BofA Securities Upgrades Texas Instruments to Neutral," January 28, 2026. https://price-target.com/2026/01/28/170375/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TXN trades at $264. The 17 analysts who set a target in the last 3 months range from $250 to $370, with a median of $330. This $235 target is 29% below the median, the lowest on the Street.

Since the note TXN has moved +34% (from $197). 12-month window: day 297 of 365, closes on January 28, 2027.

Track record

This call✓ Target reached on April 22, 2026, 3 months after the note.

Firm track recordBank of America: 79% of its 67 targets at least a year old were reached within 12 months (#11 of 29 firms). Accuracy ranking →

Earnings reactionOne of 15 notes after Texas Instruments’s Jan 27 results: 15 raised · 0 cut · 0 kept. See every call →

Bank of America on Texas Instruments

Bank of America price targets on Texas Instruments

3 calls from January 28, 2026 to April 24, 2026. The target went from $235 to $320 (+36%). The rating moved from Hold to Buy.

Bank of America targetTXN share price
  1. April 24, 2026Kept the $320 targetBuy$320
  2. April 23, 2026Upgraded to Buy, target raised from $235 (+36%)Buy$320
  3. January 28, 2026 This noteEarliest call shownHold$235
Share Reddit StockTwits
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.